BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The success of gene therapy hinges on overcoming the immunogen
 icity challenges of viral vectors. With more viral vector-based gene ther
 apies progressing through the pipeline\, we need to seek solutions to thi
 s critical bottleneck 'here and now'.\n\nThe 5th Gene Therapy Immunogenic
 ity Summit is returning to Boston this August\, bringing together 100+ im
 munogenicity experts responsible for predicting\, measuring\, and mitigat
 ing immune response. Join your colleagues as they share their learnings a
 nd gain key insights on:\n\n* Effective approaches to promote AAV safety 
 whilst maintaining efficacy* Preventing the bottlenecks of the potential 
 slowdown of gene therapy development* Access specific\, case-study-led ex
 amples across immunogenicity and ask the big-hitting immunology questions
  to your peers actively working in the space to make clinically safe and 
 effective gene therapies a reality.* Predicting and mitigating against co
 mplement activation and other toxicity issues with Ask Bio\, Takeda\, and
  Novartis* Validating novel Immunoassays\, bioanalytical and biodistribut
 ion technology with Astellas Gene Therapies and Boehringer Ingelheim* Und
 erstanding possible risks around exacerbation of both the innate and adap
 tive immune response with Roche and Tenaya Therapeutics* Exploring the pr
 acticalities of AAV redosing through an immunology lens with the Universi
 ty of Indiana and Adolore Biotherapeutics* Examine the immunogenicity ris
 ks specific to gene editing approached as momentum in the field increases
  with CRISPR and Modalis Therapeutics\n\n&nbsp\;\n\nTime: 8:30 AM - 4:00 
 PM\n
DTEND:20240822T160000
DTSTAMP:20260512T214300Z
DTSTART:20240820T083000
LOCATION:The Westin Boston Seaport District\, 425\, Summer Street\, Boston
 \, Massachusetts\, 02210\,
SEQUENCE:0
SUMMARY:The success of gene therapy hinges on overcoming the immunogenicit
 y challenges of viral vectors. With more viral vector-based gene therapie
 s progre...
UID:5bc429b8-a90c-490c-9334-8effe95c3745
END:VEVENT
END:VCALENDAR